Friday 30 June 2023

Biofilter Market By Aquael, Aquaneering, Inc.; AZOO BIO CORPORATION; EHEIM GmBh & Co. KG; Pentair Aquatic Eco-systems, Inc

 


The global Biofilter Market size is expected to reach USD 4.11 billion by 2030 and is expected to expand at 9.14% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by rising water pollution and the global spread of waterborne diseases. According to CDC, in the U.S., waterborne pathogens are estimated to cause 7.2 million diseases, 118,000 hospitalizations, and 6,630 deaths each year. This has significantly increased the need to manage wastewater in order for it to be used for a variety of purposes. Furthermore, rising fish consumption also benefits biofilter manufacturers in aquaculture & fisheries and further boosts market growth.

The increased demand for aquarium fish is projected to drive continued growth for biofilters in the future years. To meet rising demand, several companies concentrate their efforts on product innovation & technological advancements. For instance, in April 2021, CerMedia LLC introduces the MarinePure biofilter media, which achieves this balance by offering a large surface area for the good bacteria that will decompose these pollutants. Furthermore, associated benefits connected with biofilters such as affordability, ecological sustainability, and widespread accessibility in various designs & sizes, and others, are likely to boost biofiltration industry expansion during the projection period.

Biofilters is also used to treat domestic wastewater. This is expected to drive the biofiltration industry forward. To make it safe for drinking, biofilteration technology can efficiently remove microbiological pollutants and organic and inorganic hazardous substances. The increased need for wastewater treatment technologies in emerging nations is likely to drive the global biofilteration industry over the coming years. For instance, in February 2021, the industrial Services of Geneva (SIG) extended the contract for biological treatment using biofiltration at the Aïre wastewater treatment plant in Geneva. The contract is one of the initial steps in the "Aïre 2+" initiative, which intends to develop the facility into an all-encompassing environmental tool.

The need for biofilters to prevent a wide range of infections has increased as a result of the COVID-19 pandemic. The development of biofilter applications enables the expansion of new approaches for the prevention and detection of waterborne diseases & other viral infections. However, the imposition of lockdowns impeded the biofiltration industry’s growth for a few years.

Furthermore, there has been a distinguishable trend toward association in recent years, with players trying to form strategic associations to support the industry’s growth. For instance, in July 2022, the US department of agriculture awarded a $300,000 grant to a researcher in Penn State's college of agricultural sciences. The grant is aimed at reducing methane from enteric emissions generated in livestock facilities with the help of biofiltration. Such emissions arising at meat production facilities remain a major concern for the environment. Hence, environmental concerns, sustainability initiatives, and subsequent research and development continue to propel the industry’s growth.

Related Press Release@ Biofilter Market Report

List of Key Players in the Biofilter Market

  • Aquael
  • Aquaneering, Inc.
  • AZOO BIO CORPORATION
  • EHEIM GmBh & Co. KG
  • Pentair Aquatic Eco-systems, Inc
  • Veolia Water Technologies
  • Aqua Design Amano Co.,Ltd.
  • Zoo Med Laboratories, Inc.
  • Waterlife Research Ind. Ltd.

Biofilter Market Report Highlights

  • By type, the biological aerated biofilter system segment accounted for the largest share in 2022. These remain popular due to the numerous advantages such as compact process, lack of need for secondary settlers, and quick recovery after a problem
  • By filter media, the ceramic rings segment held a large share in 2022. Ceramic rings are gaining popularity as a low-cost and efficient bio medium. These are ideal in setting such as aquariums due to high biocompatibility, and extensive application
  • By application, the VOC treatment segment held a large share in 2022. This is attributed to the increasing air pollution and associated infections
  • By end-user, aquaculture held a large share in 2022. The growing demand for land-based aquariums & fisheries is expected to make a notable contribution to the revenue growth
  • North America held the largest share in 2022. The U.S. is one of the major markets for biofilters due to rigorous water quality regulations and rising environmental consciousness among industry sectors such as food processing, pharma, and others
  • The Asia Pacific is expected to grow at the highest rate during the forecast period. India is a major market for bio-filtration products due to rigorous water quality requirements, high pollution levels and rising prevalence of waterborne diseases

Biofilter Market Report Scope

Report Attribute

Details

Market size value in 2023

USD 2,232.8 million

Revenue forecast in 2030

USD 4.11 billion

Growth rate

CAGR of 9.14% from 2023 to 2030

Base year for estimation

2022

Historical data

2018 - 2021

Forecast period

2023 - 2030

 

Related Report @
Protein Labeling Market

Aptamers Market

Biofilter Market Segmentation

Grand view research has segmented the global biofilter market based on type, filter media, application, end-user, and region:

Biofilter Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Biological Aerated Biofilter System
  • Denitrification Biofilter Systems
  • Activated Carbon Biofilters
  • Fixed Films
  • Fluidized Bed Filter

Biofilter Filter Media Outlook (Revenue, USD Million, 2018 - 2030)

  • Ceramic Rings
  • Bio Balls
  • Moving Bed Filter Media
  • Others

Biofilter Application Outlook (Revenue, USD Million, 2018 - 2030)

  • VOC Treatment
  • Nitrification
  • Denitrification
  • Odor Abatement
  • Others

Biofilter End-user Outlook (Revenue, USD Million, 2018 - 2030)

  • Storm Water Management
  • Water & Wastewater Collection
  • Chemical Processing
  • Food & Beverage
  • Aquaculture
  • Biopharma Industry
  • Others

Biofilter Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-95196
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Thursday 29 June 2023

Mesenchymal Stem Cells Market Size is Predicted to Witness 12.8% CAGR till 2030

 


The global Mesenchymal Stem Cells Market size is expected to reach USD 7.21 billion by 2030. The market is expected to reach at a CAGR of 12.8% from 2023 to 2030. An exponential increase in Mesenchymal Stem Cell (MSC) based research and its implications in the field of regenerative medicine is anticipated to fuel the industry expansion. Moreover, the constantly evolving landscape of cell therapies is also anticipated to propel investments in the mesenchymal stem cells market space; large-scale operational firms are targeting small or emerging players with an operating strategy of acquisition to bolster their market presence.

The strong pipeline of mesenchymal stem cell-based products coupled with emerging applications of mesenchymal stem cells is anticipated to accelerate the industry growth. For instance, in 2022, the U.S.FDA has approved around 19 stem cell therapies for range of life-threatening disorders. Some of these therapies include, BREYANZI of BMS, ALLOCORD, KYMIRAH of Novartis etc. Moreover, a substantial number of companies are exploring the potential of MSCs as therapeutic regime for the management of inflammatory conditions, in turn, boosting market growth.

For instance, on January 2022, the Century Therapeutics and Bristol Myers Squibb entered a collaboration to expand IPSC-derives allogenic cell therapies. In addition, Takeda/TiGenix phase 3 clinical trial incorporated mesenchymal stem cells for complex perianal fistulas in Crohn's Disease. This was the most successful late-stage clinical trial as of September 2020. In addition, in August 2022 AGC Biologics partnered with human mesenchymal stem cell supplier, RoosterBio Inc. to deliver clinically proven advanced therapies for life-threatening conditions. These factors are projected to bolster the usage of stem cell products offered by key entities, thereby intensifying the market competition.

Market players are focused on the expansion of their offerings through extensive R&D and the formation of alliances and partnerships with other major players to sustain their market position. Owing to the recent pandemic of COVID-19, several research and academic research institutes are making focused efforts to develop a treatment regime by using mesenchymal stem cells. 

Related Press Release@ Mesenchymal Stem Cells Market Report

Mesenchymal Stem Cells Market Report Highlights 

  • The products segment dominated the segment and accounted for the largest revenue share of 78.8% in 2022. Among the products, the cells and cell lines segment has emerged as a key contributor to the segment’s revenue
  • Based on workflow type, the culture and cryopreservation segment dominated the industry with revenue share of 44.5% in 2022. The segment growth is attributed to the high demand for cryopreservation services and enhancement of healthcare infrastructure in developing economies
  • The allogenic MSCs segment accounted for the higher revenue share of 56.6% in 2022. This is attributed to the high safety profile of allogeneic mesenchymal stem cells in clinical applications
  • The bone marrow segment dominated the market and accounted for the largest revenue share of 24.52% in 2022. Bone marrow is a major source of isolation for mesenchymal cells
  • The disease modelling application segment dominated the application and accounted for the largest revenue share of 35.1% in 2022. The use of cellular disease models with patient specific MSCs provides an ideal tool for pathological research
  • North America dominated the market and accounted for the largest revenue share of 44.28% in 2022. The higher revenue share of the region is accounted to supportive government legislation and rising application of cell therapies in chronic disorders

List of Key Players in the Mesenchymal Stem Cells Market

  • Thermo Fisher Scientific, Inc
  • Cell Applications, Inc
  • Axol Biosciences Ltd
  • Cytori Therapeutics Inc
  • STEMCELL Technologies
  • Cyagen Biosciences
  • Celprogen Inc
  • BrainStorm Cell Limited
  • Stemedica Cell Technologies Inc
  • Merck KGaA (MilliporeSigma)
  • PromoCell GmbH

Mesenchymal Stem Cells Market Report Scope

Report Attribute

Details

Market size value in 2023

USD 3.10 billion

Revenue forecast in 2030

USD 7.21 billion

Growth Rate

CAGR of 12.8% from 2023 to 2030

Base year for estimation

2022

Historical data

2018 - 2021

Forecast period

2023 - 2030

 

Related Reports@
Stem Cells Market

Human Embryonic Stem Cells Market

Mesenchymal Stem Cells Market Segmentation 

Grand View Research has segmented the global mesenchymal stem cells market based on products and services, workflow, type, source of isolation, indication, application, and region: 

Mesenchymal Stem Cells Product & Services Outlook (Revenue, USD Million, 2018 - 2030)

  • Products
    • Cells & Cell Lines
    • Kits, Media, & Reagents
    • Others
  • Services

Mesenchymal Stem Cells Workflow Outlook (Revenue, USD Million, 2018 - 2030)

  • Cell Sourcing & Isolation
  • Culture & Cryopreservation
  • Differentiation
  • Characterization

Mesenchymal Stem Cells Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Autologous
  • Allogeneic

Mesenchymal Stem Cells Source of Isolation Outlook (Revenue, USD Million, 2018 - 2030)

  • Bone Marrow
  • Cord Blood
  • Peripheral Blood
  • Fallopian Tube
  • Fetal Liver
  • Lung
  • Adipose Tissues

Mesenchymal Stem Cells Indication Outlook (Revenue, USD Million, 2018 - 2030)

  • Bone And Cartilage Repair
  • Cardiovascular Disease
  • Inflammatory And Immunological Diseases
  • Liver Diseases
  • Cancer
  • GvHD
  • Others

Mesenchymal Stem Cells Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Disease Modelling
  • Drug Development & Discovery
  • Stem Cell Banking
  • Tissue Engineering
  • Toxicology Studies
  • Others

Mesenchymal Stem Cells Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Norway
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait 

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-95196
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Friday 23 June 2023

Microcurrent Facial Market Size is Predicted to Witness 7.3% CAGR till 2030


 The global Microcurrent Facial Market size is expected to reach USD 652.0 million by 2030, expanding at a CAGR of 7.3% over the forecast period, according to a new report by Grand View Research, Inc. The increasing demand for non-surgical procedures for better aesthetic looks and rising awareness for anti-aging treatment among consumers are the major growth-propelling factors for the market.

In facial aesthetic applications, microcurrent treatments are used to stimulate the face muscles that fuel collagen production and tighten skin appearance. Microcurrent stimulates adenosine triphosphate cell growth and collagen development in the dermis of the face by using low-voltage electricity. The microcurrent facial device uses two portable prongs that supply precise amounts of energy to the skin while simultaneously repairing and producing collagen in the dermis and gradually erasing signs of aging in the epidermis.

Microcurrent stimulation also provides non-cosmetic health benefits. For instance, according to a report of BioMed Central Ltd. 2019, daily administration of microcurrent therapy can decrease facial pain from sinus congestion for up to 6 hours. Over the course of four weeks, it also reduces congestion and pain. Clinical studies show that microcurrent treatment increases blood circulation by 38%, collagen production by 14%, and elastin production by 48% in just 20 days

The cosmetic surgery industry witnessed significant setbacks due to the COVID-19 pandemic in the second and third quarters of 2020. According to Springer, COVID-19 negatively impacted non-surgical treatment especially in the initial quarters of 2020, due to restrictions on aesthetic treatments and operations of aesthetic clinics, medspas, etc. However, the pandemic resulted in an increase in virtual consultations. For instance, as per the report, the U.S. experienced a 64% rise in online consultation requests, as patients were considering treatments to be done after the pandemic.

List of Key Players in the Microcurrent Facial Market

  • Skin Body Health Clinic
  • Skintherapy
  • American Face and Body Clinic
  • Medicis Medical Spa
  • SkinLab USA
  • Skinglow Clinic
  • Wyndham Place Clinic
  • Enhance Aesthetics and Laser Clinic
  • The Ottawa Skin Clinic
  • Renajo Skin Clinic

Related Press Release@ Microcurrent Facial Market Report

Microcurrent Facial Market Highlights

  • Skin tightening segment held the largest market share in 2022 and is expected to showcase the fastest growth over the forecast period due to technological advancements in skin-tightening devices
  • The medspa segment held the largest share in 2022 owing to the increasing consumer awareness for self-care
  • The in-home segment is expected to showcase lucrative growth over the forecast period as it is a cost-efficient and easy way of getting microcurrent facial
  • North America accounted for the largest market share in 2022 due to the high awareness and acceptance of non-invasive procedures
  • Some of the major players include Skin Body Health Clinic, Skintherapy, and American Face and Body Clinic

Related Reports@

Facial Care Market

Facial Implant Market

Microcurrent Facial Market Segmentation

Grand View Research has segmented the global microcurrent facial market based on application, end-use, and region:

Microcurrent Facial Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Anti-aging
  • Skin Tightening
  • Skin Rejuvenation
  • Others (Dark circle reduction, minor contouring)

Microcurrent Facial End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Medspa
  • At-home
  • HCP-owned clinic

Microcurrent Facial Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com

Digital Pathology Market Size To Reach $1.73 Billion By 2030

The global  Digital Pathology Market  size is expected to reach USD 1.73 billion by 2030, registering a CAGR of 8.0% from 2024 to 2030, acco...